Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Enoxaparin Dose Adaptation in Patients With Moderate Renal Failure Hospitalized for an Acute Coronary Syndrome, the VALIDE Study

NCT00412802 is registered in ClinicalTrials.gov with French Cardiology Society as lead sponsor.

NCT NCT00412802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00412802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Enoxaparin Dose Adaptation in Patients With Moderate Renal Failure Hospitalized for an Acute Coronary Syndrome, the VALIDE Study
Lead sponsor
French Cardiology Society
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2006
Completion date
March 31, 2009
Enrollment
67 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, renal failure